At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Dizziness and Neck Pain: A Perspective on Cervicogenic Dizziness
Cervicogenic dizziness is a somewhat controversial topic, as this condition is often considered a diagnosis of exclusion without a specific objective standardized test across health-care…
Audiologists Advocate for Fair Use of “Doctor” Title in Florida
This week, the American Academy of Audiology, in collaboration with the Florida Academy of Audiology (FLAA), voiced concerns about House Bill (HB) 1341—legislation that would…
Arkansas Enacts Law Expanding Audiologists’ Scope of Practice
Arkansas Senate Bill 118 has been signed into law, updating the state’s audiology scope of practice statute. The law allows audiologists who are licensed to…